Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Zheng-Yi Zhou · SciRah

Researcher profile · Semantic Scholar

Zheng-Yi Zhou

Share profile

Zheng-Yi Zhou — researcher profile on SciRah

h-index: 17
Works: 60
Citations: 987

Most-cited papers

Economic Impact of Next-Generation Sequencing Versus Single-Gene Testing to Detect Genomic Alterations in Metastatic Non-Small-Cell Lung Cancer Using a Decision Analytic Model.
N. Pennell, Alex Mutebi, Zheng-Yi Zhou, M. Ricculli +9 more
2019JCO Precision Oncology176 citations
Semantic Scholar
Burden of illness: direct and indirect costs among persons with hemophilia A in the United States
Zheng-Yi Zhou, M. Koerper, Kathleen A. Johnson, B. Riske +6 more
2015Journal of Medical Economics128 citations Open access
Semantic Scholar
Costs of care in hemophilia and possible implications of health care reform.
Kathleen A. Johnson, Zheng-Yi Zhou
2011Hematology. American Society of Hematology. Education Program65 citations Open access
Semantic Scholar
Investigation of adverse-event-related costs for patients with metastatic breast cancer in a real-world setting.
S. Hurvitz, A. Guerin, M. Brammer, Ellie Guardino +4 more
2014The Oncologist57 citations Open access
Semantic Scholar
Comparative Efficacy of Ceritinib and Crizotinib as Initial ALK–Targeted Therapies in Previously Treated Advanced NSCLC: An Adjusted Comparison with External Controls
D. S. Tan, A. Araújo, Jie Zhang, J. Signorovitch +3 more
2016Journal of Thoracic Oncology45 citations Open access
Semantic Scholar
Economic impact of next generation sequencing vs sequential single-gene testing modalities to detect genomic alterations in metastatic non-small cell lung cancer using a decision analytic model.
N. Pennell, Alex Mutebi, Zheng-Yi Zhou, M. Ricculli +6 more
201836 citations
Semantic Scholar
Cost-Effectiveness of Neoadjuvant Pembrolizumab Plus Chemotherapy Followed by Adjuvant Single-Agent Pembrolizumab for High-Risk Early-Stage Triple-Negative Breast Cancer in the United States
Min Huang, P. Fasching, A. Haiderali, Wei-Guang Xue +8 more
2023Advances in Therapy34 citations Open access
Semantic Scholar
Model of Short- and Long-Term Outcomes of Emicizumab Prophylaxis Treatment for Persons with Hemophilia A
Zheng-Yi Zhou, K. Raimundo, Anisha M. Patel, Simeng Han +5 more
2020Journal of Managed Care & Specialty Pharmacy31 citations Open access
Semantic Scholar
Cost-effectiveness of pembrolizumab for the adjuvant treatment of resected high-risk stage III melanoma in the United States
A. Bensimon, Zheng-Yi Zhou, M. Jenkins, Yan Song +6 more
2019Journal of Medical Economics31 citations Open access
Semantic Scholar
Self-reported barriers to hemophilia care in people with factor VIII deficiency.
Zheng-Yi Zhou, B. Riske, A. Forsberg, M. Ullman +6 more
2011American Journal of Preventive Medicine29 citations Open access
Semantic Scholar
Economic Evaluations of Everolimus Versus Other Hormonal Therapies in the Treatment of HR+/HER2- Advanced Breast Cancer From a US Payer Perspective.
Jipan Xie, Y. Hao, Zheng-Yi Zhou, Cynthia Z. Qi +2 more
2015Clinical Breast Cancer26 citations
Semantic Scholar
Cost-effectiveness of pembrolizumab plus chemotherapy as first-line treatment in PD-L1-positive metastatic triple-negative breast cancer.
Min Huang, P. Fasching, A. Haiderali, W. Pan +7 more
2022Immunotherapy24 citations Open access
Semantic Scholar
An indirect comparison and cost per responder analysis of adalimumab, methotrexate and apremilast in the treatment of methotrexate-naïve patients with psoriatic arthritis
K. Betts, J. Griffith, A. Friedman, Zheng-Yi Zhou +2 more
2016Current Medical Research and Opinion24 citations
Semantic Scholar
Economic Burden of Illness Among Commercially Insured Patients with Systemic Sclerosis with Interstitial Lung Disease in the USA: A Claims Data Analysis
Zhou Zhou, Yanni Fan, Darren Thomason, Wen-Xi Tang +4 more
2019Advances in Therapy23 citations Open access
Semantic Scholar
Cost-effectiveness of ceritinib in previously untreated anaplastic lymphoma kinase-positive metastatic non-small cell lung cancer in the United States
Zheng-Yi Zhou, Alex Mutebi, Simeng Han, A. Bensimon +4 more
2018Journal of Medical Economics22 citations Open access
Semantic Scholar
Clinical and Economic Impact of Upfront Next-Generation Sequencing for Metastatic NSCLC in East Asia
H. H. Loong, C. Wong, C. Chan, A. Chang +3 more
2022JTO Clinical and Research Reports21 citations Open access
Semantic Scholar
An Economic Evaluation of Pembrolizumab Versus Other Adjuvant Treatment Strategies for Resected High-Risk Stage III Melanoma in the USA
A. Bensimon, Zheng-Yi Zhou, M. Jenkins, Yan Song +6 more
2020Clinical drug investigation20 citations Open access
Semantic Scholar
Cost-effectiveness of ceritinib in patients previously treated with crizotinib in anaplastic lymphoma kinase positive (ALK+) non-small cell lung cancer in Canada
M. Hurry, Zheng-Yi Zhou, Jie Zhang, Chenxue Zhang +3 more
2016Journal of Medical Economics17 citations Open access
Semantic Scholar
Economic Burden among Commercially Insured Patients with Systemic Sclerosis in the United States
Zhou Zhou, Yanni Fan, Wen-Xi Tang, Xin-Yue Liu +4 more
2019Journal of Rheumatology15 citations
Semantic Scholar
Budget Impact Analysis of Liposomal Amphotericin B and Amphotericin B Lipid Complex in the Treatment of Invasive Fungal Infections in the United States
Hong-Bo Yang, P. Chaudhari, Zheng-Yi Zhou, E. Wu +2 more
2014Applied Health Economics and Health Policy15 citations
Semantic Scholar
Efficacy of bypassing agents in patients with hemophilia and inhibitors: a systematic review and meta-analysis.
Zheng-Yi Zhou, J. Hay
2012Clinical Therapeutics15 citations
Semantic Scholar
Cost-effectiveness analysis of ceritinib vs. crizotinib in previously untreated anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) in Hong Kong
H. Loong, Carlos K. H. Wong, L. K. S. Leung, C. Chan +4 more
2020Cost Effectiveness and Resource Allocation14 citations Open access
Semantic Scholar
Economic Burden of Switching to a Non-Tumor Necrosis Factor Inhibitor Versus a Tumor Necrosis Factor Inhibitor Biologic Therapy among Patients with Rheumatoid Arthritis
Zheng-Yi Zhou, J. Griffith, E. Du, Daniel Chin +2 more
2016Advances in Therapy13 citations
Semantic Scholar
Systematic literature review of economics analysis on treatment of mild-to-moderate bleeds with aPCC versus rFVIIa
J. Hay, Zheng-Yi Zhou
2011Journal of Medical Economics13 citations Open access
Semantic Scholar
Budget impact of capmatinib for adults with metastatic non-small cell lung cancer harboring a MET exon 14 skipping mutation in the United States
B. Cai, Zheng-Yi Zhou, W. Xue, Nisha C. Hazra +5 more
2021Journal of Medical Economics11 citations Open access
Semantic Scholar
Transparency in Health Economic Modeling: Options, Issues and Potential Solutions
E. Wu, Zheng-Yi Zhou, Jipan Xie, C. Metallo +1 more
2019PharmacoEconomics (Auckland)9 citations Open access
Semantic Scholar
Comparative Efficacy of Treatments for Previously Treated Advanced or Metastatic Non-Small-Cell Lung Cancer: A Network Meta-Analysis
Jun-Long Li, M. Sasane, Jing Zhao, Viviana Garcia Horton +4 more
2018Advances in Therapy9 citations
Semantic Scholar
Real-World Outcomes of Trilaciclib Among Patients with Extensive-Stage Small Cell Lung Cancer Receiving Chemotherapy
J. Goldschmidt, L. Hart, J. Scott, Kristen Boykin +14 more
2023Advances in Therapy7 citations Open access
Semantic Scholar
Matching-Adjusted Indirect Comparisons of Filgotinib vs Vedolizumab, Tofacitinib, and Ustekinumab for Moderately to Severely Active Ulcerative Colitis
Xiaoyan Lu, Zheng-Yi Zhou, Y. Xin, Min-Jung Wang +3 more
2023Inflammatory Bowel Diseases7 citations Open access
Semantic Scholar
Economic burden during remission and after relapse among older patients with newly diagnosed acute myeloid leukemia without hematopoietic stem cell transplant: A retrospective study using the SEER-Medicare database.
A. Brunner, D. Huggar, R. Copher, Zheng-Yi Zhou +4 more
2023Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis6 citations Open access
Semantic Scholar
Matching‐adjusted indirect comparison of isatuximab plus carfilzomib and dexamethasone with daratumumab plus lenalidomide and dexamethasone in relapsed multiple myeloma
J. Richter, Peggy L. Lin, V. Garcia-Horton, P. Guyot +4 more
2023Cancer Medicine5 citations Open access
Semantic Scholar
Economic Evaluation of Timely Versus Delayed Use of Tumor Necrosis Factor Inhibitors for Treatment of Psoriatic Arthritis in the US
V. Strand, E. Husni, J. Griffith, Zheng-Yi Zhou +2 more
2016Rheumatology and Therapy5 citations Open access
Semantic Scholar
Prevalence of ocular comorbidities in patients with multiple myeloma: An analysis of U.S. claims data.
S. Ailawadhi, Qiufei Ma, J. Jalbert, Mo Zhou +10 more
2022Journal of Clinical Oncology4 citations
Semantic Scholar
Medication use in adults with attention deficit/hyperactivity disorder in a commercially-insured population in the United States
Zhou Zhou, Zheng-Yi Zhou, S. Kelkar, V. Sikirica +2 more
2018Current Medical Research and Opinion4 citations
Semantic Scholar
Association between time to progression and subsequent survival inceritinib-treated patients with advanced ALK-positive non-small-cell lung cancer
Geoffrey Liu, Jie Zhang, Zheng-Yi Zhou, Jun-Long Li +2 more
2016Current Medical Research and Opinion4 citations
Semantic Scholar
Cost-Effectiveness Analysis of Lenalidomide for Maintenance Therapy after Autologous Stem Cell Transplant (ASCT) in Newly Diagnosed Multiple Myeloma (NDMM) Patients: A United States Payer Perspective
Zheng-Yi Zhou, K. Parikh, X. Chai, Ariel Rokito +3 more
2018Blood3 citations
Semantic Scholar
Comparative Efficacy of Ceritinib and Crizotinib as Initial Anaplastic Lymphoma Kinase-targeted Therapies in Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer: an Adjusted Comparison to External Controls.
D. Tan, A. Araújo, Jie Zhang, J. Signorovitch +3 more
20163 citations
Semantic Scholar
Comparative efficacy of ceritinib and crizotinib in previously treated crizotinib-naïve anaplastic lymphoma kinase-positive (ALK+) advanced or metastatic non-small cell lung cancer (NSCLC): An adjusted indirect comparison.
D. Tan, A. Araújo, Jie Zhang, J. Signorovitch +3 more
20153 citations
Semantic Scholar
Comprehensive investigation of adverse event (AE)-related costs in patients with metastatic breast cancer (MBC) treated with first- and second-line chemotherapies.
S. Hurvitz, A. Guerin, M. Brammer, Ellie Guardino +4 more
20123 citations
Semantic Scholar
Prevalence of Ocular Comorbidities in Elderly Patients with Multiple Myeloma in the US: An Analysis of 100% Medicare Sample Data during 2007-2020
S. Ailawadhi, Qiufei Ma, J. Jalbert, Mo Zhou +10 more
2022Blood2 citations Open access
Semantic Scholar
Health resource use and costs of vilazodone and other selective serotonin re-uptake inhibitors in treating major depressive disorder
Zheng-Yi Zhou, Shawn X. Sun, P. Chopra, Y. Zhong +2 more
2015Journal of Medical Economics2 citations Open access
Semantic Scholar
A Model Estimating Indirect Costs of Premature Death Associated with Severe Hepatic Veno-Occlusive Disease (sVOD) Among Hematopoietic Stem Cell Transplant (HSCT) Patients in the United States (U.S.)
T. Quock, Zheng-Yi Zhou, Byran Dai, Wen-Xi Tang +1 more
20152 citations Open access
Semantic Scholar
Quality-Adjusted Time Without Symptoms Of Disease Progression Or Toxicity Analysis Of Mirvetuximab Soravtansine Versus Investigator’s Choice Of Chemotherapy In Folate Receptor-Alpha Positive, Platinum-Resistant Ovarian Cancer
F. Hilpert, T. van Gorp, C. Cosgrove, M. Kaminsky +12 more
2025International Journal of Gynecological Cancer1 citations
Semantic Scholar
Economic Burden of Newly Diagnosed Acute Myeloid Leukemia: A Retrospective Study Using the SEER-Medicare Database
A. Tabah, D. Huggar, K. Huey, R. Copher +4 more
20201 citations Open access
Semantic Scholar
HSR19-106: Association Between Pathological Complete Responses and Long-Term Survival Outcomes Among Triple-Negative Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
Cynthia Z. Qi, Min Huang, A. Haiderali, Jipan Xie +3 more
2019The Journal of the National Comprehensive Cancer Network1 citations
Semantic Scholar
Treatment patterns among adults with ADHD receiving long-acting therapy.
Zhou Zhou, Zheng-Yi Zhou, Sneha S Kellar, V. Sikirica +2 more
2018American Journal of Managed Care1 citations
Semantic Scholar
Treatment Patterns and Healthcare Resource Utilization in Patients with Relapsed/Refractory Acute Myeloid Leukemia and a Subset with IDH1-Mutation: A United States Medical Chart Review Study
J. Griffin, Michael Storm, K. Wilhelm, A. Boscoe +4 more
2018Blood1 citations
Semantic Scholar
Cost-Effectiveness Of Ceritinib In Previously Treated Patients With Crizotinib In Anaplastic Lymphoma Kinase-Positive (Alk+) Non-Small Cell Lung Cancer In Canada.
Zheng-Yi Zhou, M. Hurry, Jie Zhang, Liangyi Fan +2 more
2015Value in Health1 citations Open access
Semantic Scholar
Prevalence and disease burden of alpha-1 antitrypsin deficiency in Germany
Kuen-Cheh Yang, Ina Jazic, Christina Scirica, Zheng-Yi Zhou +2 more
2023Epidemiology0 citations
Semantic Scholar
AML-430 A Surveillance, Epidemiology, and End Results (SEER)-Medicare Analysis of the Economic Burden Among Elderly Patients With Acute Myeloid Leukemia (AML) Treated With Hypomethylating Agents (HMA).
A. McBride, D. Huggar, R. Copher, Zheng-Yi Zhou +4 more
2022Clinical Lymphoma, Myeloma & Leukemia0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

J. Signorovitch×10
Invite
J. Signorovitch — researcher profile on SciRah
Jipan Xie×10
Invite
Jipan Xie — researcher profile on SciRah
Wen-Xi Tang×6
Invite
Wen-Xi Tang — researcher profile on SciRah
E. Wu×5
Invite
E. Wu — researcher profile on SciRah

×5

Invite

Jie Zhang — researcher profile on SciRah

Invite

A. Guerin — researcher profile on SciRah

Xiao-Peng Cai×4

Invite

Xiao-Peng Cai — researcher profile on SciRah

Geoffrey Liu×4

Invite

Geoffrey Liu — researcher profile on SciRah

Invite

Zhou Zhou — researcher profile on SciRah

Invite

N. Downes — researcher profile on SciRah

Invite

Alex Mutebi — researcher profile on SciRah

Invite

M. Ricculli — researcher profile on SciRah